Hydroxychloroquine sulphate in the treatment of rheumatoid arthritis: a double blind comparison of two dose regimens.
Authors:
- K PavelkaKPK Pavelka
- K.P SenKSK.P Sen
- Z PelískováZPZ Pelísková
- J VáchaJVJ Vácha
- K TrnavskýKTK Trnavský
Open Access
- 1 July 1989
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 48 (7) , 542-546
Abstract
A controlled, double blind, parallel group, long term study of hydroxychloroquine sulphate in the treatment of rheumatoid arthritis, comparing daily doses of 200 mg and 400 mg, is described. The trial involved 54 patients with moderate disease activity who had not previously received antimalarial drugs. Forty three patients completed the one year treatment. The groups receiving different doses were homogeneous and did not differ in any of the 25 monitored indicators. Both dose regimens were effective, and a significant reduction of disease activity was observed after one year's treatment. Of the nine laboratory and 11 clinical indices of efficacy monitored, no statistically significant differences were reported, but in the group of patients treated with the 400 mg daily dose the number of side effects was three times greater. As there have been no reports of retinopathy with hydroxychloroquine at daily doses of 200 mg the effectiveness of this dose is of practical importance.Keywords
This publication has 18 references indexed in Scilit:
- Variation in chloroquine pharmacokinetics due to assay sensitivity and duration of samplingEuropean Journal of Clinical Pharmacology, 1987
- Controlled trial of hydroxychloroquine and d‐penicillamine singly and in combination in the treatment of rheumatoid arthritisArthritis & Rheumatism, 1984
- Hydroxychloroquine sulfate in rheumatoid arthritis: Long-term response rate and predictive parametersThe American Journal of Medicine, 1983
- Dose refinements in long-term therapy of rheumatoid arthritis with antimalarialsThe American Journal of Medicine, 1983
- Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapyThe American Journal of Medicine, 1983
- Risk/benefit analysis of hydroxychloroquine sulfate treatment in rheumatoid arthritisThe American Journal of Medicine, 1983
- Antimalarials in Rheumatic DiseasesAustralian and New Zealand Journal of Medicine, 1982
- Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquineJAMA, 1982
- Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes.BMJ, 1977
- Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalitiesArthritis & Rheumatism, 1971